Lunli Zhang

763 total citations
27 papers, 299 citations indexed

About

Lunli Zhang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Lunli Zhang has authored 27 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Lunli Zhang's work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Lunli Zhang is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Lunli Zhang collaborates with scholars based in China, United States and Hong Kong. Lunli Zhang's co-authors include Yufei Shi, Ming Li, Aiping Le, Wenfeng Zhang, Zhenping Wu, Xiaopeng Li, Xiaolan Yang, Qian Yang, Tianxin Xiang and Li Ming and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Lunli Zhang

27 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lunli Zhang China 10 106 94 75 50 50 27 299
Inge M. Westra Netherlands 9 76 0.7× 115 1.2× 66 0.9× 52 1.0× 11 0.2× 16 313
Xiucheng Pan China 11 150 1.4× 86 0.9× 95 1.3× 74 1.5× 27 0.5× 24 459
Yixiang Zheng China 13 159 1.5× 94 1.0× 220 2.9× 52 1.0× 51 1.0× 24 500
Guiwen Guan China 12 160 1.5× 123 1.3× 146 1.9× 47 0.9× 56 1.1× 28 453
Premashish Kar India 11 150 1.4× 255 2.7× 45 0.6× 28 0.6× 17 0.3× 32 402
Cunliang Deng China 10 107 1.0× 52 0.6× 73 1.0× 32 0.6× 30 0.6× 38 273
Kung‐Chia Young Taiwan 10 290 2.7× 291 3.1× 153 2.0× 41 0.8× 42 0.8× 16 630
Xuwen Xu China 9 94 0.9× 40 0.4× 274 3.7× 48 1.0× 255 5.1× 29 485
Zhaoxia Tan China 11 170 1.6× 180 1.9× 39 0.5× 27 0.5× 54 1.1× 27 353
Yana Davidov Israel 7 200 1.9× 115 1.2× 65 0.9× 20 0.4× 7 0.1× 28 380

Countries citing papers authored by Lunli Zhang

Since Specialization
Citations

This map shows the geographic impact of Lunli Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lunli Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lunli Zhang more than expected).

Fields of papers citing papers by Lunli Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lunli Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lunli Zhang. The network helps show where Lunli Zhang may publish in the future.

Co-authorship network of co-authors of Lunli Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lunli Zhang. A scholar is included among the top collaborators of Lunli Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lunli Zhang. Lunli Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Wei, et al.. (2020). Hereditary Spherocytosis Associated with Gilbert Syndrome Diagnosed with Liver Biopsy Examination and Exome Sequencing. Journal of College of Physicians And Surgeons Pakistan. 30(2). 213–215. 2 indexed citations
2.
Li, Can, Jiayu Chen, Shu-Hui Dong, et al.. (2020). Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma. PLoS ONE. 15(6). e0234062–e0234062. 7 indexed citations
3.
Zhang, Siying, et al.. (2020). Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report. Diagnostic Pathology. 15(1). 39–39. 7 indexed citations
4.
Chen, Silin, Xiaopeng Li, Ming Li, et al.. (2020). Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation. Gastroenterología y Hepatología. 43(6). 293–300. 5 indexed citations
5.
Yang, Qian, et al.. (2019). miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma. Bioscience Reports. 39(5). 26 indexed citations
6.
Shi, Chao, Hui Xu, Junyu Liu, et al.. (2019). Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma. Translational Cancer Research. 8(1). 238–247. 1 indexed citations
7.
Liu, Chengyuan, et al.. (2017). Clinical Characteristics of Patients with Drug-induced Liver Injury.. SHILAP Revista de lepidopterología. 130(2). 160–164. 11 indexed citations
8.
Wang, Hongmei, et al.. (2017). Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3. Medicine. 96(50). e9158–e9158. 4 indexed citations
9.
Wu, Zhenping, et al.. (2017). Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer. Medicine. 96(51). e9431–e9431. 33 indexed citations
11.
Zou, Wei & Lunli Zhang. (2017). Mouse Models for Studies of In Vivo Functions of HIV-1 Nef.. PubMed. 18(3). 158–165. 3 indexed citations
12.
13.
Dai, Xi‐jian, Bixia Liu, Heng Liu, et al.. (2014). Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient. Neuropsychiatric Disease and Treatment. 11. 21–21. 8 indexed citations
14.
Gong, Zhenghua, Jialin Tang, Tianxin Xiang, et al.. (2013). Association between Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES) -28C/G Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis. PLoS ONE. 8(4). e60683–e60683. 9 indexed citations
15.
Cheng, Na, Tianxin Xiang, Xiaoping Wu, et al.. (2013). Acute fatty liver of pregnancy: a retrospective study of 32 cases in South China. The Journal of Maternal-Fetal & Neonatal Medicine. 27(16). 1693–1697. 25 indexed citations
16.
Hu, Guoxin, et al.. (2012). [Effects of hydroxycamptothecin on TGFb1, a-SMA and collagen I expression in rat hepatic satellite cells].. PubMed. 20(6). 453–7. 5 indexed citations
17.
Cheng, Xiaoyu & Lunli Zhang. (2010). [The significance of CD14 and TLR4 expressions in severe hepatitis B induced by endotoxin].. PubMed. 18(6). 428–32. 3 indexed citations
18.
Zhang, Li, Yufei Shi, Xiaolan Yang, et al.. (2002). Molecular Adsorbent Recirculating System: clinical experience in patients with liver failure based on hepatitis B in China. Liver International. 22(s2). 48–51. 15 indexed citations
19.
Shi, Yufei, Jianxing He, Li Zhang, et al.. (2002). MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning – a case report. Liver International. 22(s2). 78–80. 37 indexed citations
20.
Wang, Haiping, Lunli Zhang, Maura Dandri, & Charles E. Rogler. (1998). Antisense Downregulation of N- myc1 in Woodchuck Hepatoma Cells Reverses the Malignant Phenotype. Journal of Virology. 72(3). 2192–2198. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026